Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Vous êtes Dr Adelina Constantin ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Adelina Constantin est rhumatologue à Mulhouse (68051). Il consulte à HOPITAL EMILE MULLER, 20 Rue DU DR LAENNEC, 68051 Mulhouse.
Consulter
Dr Adelina Constantin, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
Rhumatologie (SM) — Diplôme d'études spécialisées
Diplôme éq d'un pays de l'EEE profession Médecin — Capacité / certificat d'études spéciales
Les plus citées
2022Arthritis & rheumatology (Hoboken, N.J.)96 citations
A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease
2021Rheumatology (Oxford, England)47 citations
VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy
2021RMD open24 citations
Lymphoma complicating rheumatoid arthritis: results from a French case-control study
En bref
Dr Adelina Constantin consulte à HOPITAL EMILE MULLER, 20 Rue DU DR LAENNEC, 68051 Mulhouse. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 03 89 64 64 64 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Mulhouse, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Effects of Air Pollution Exposure and the MUC5B rs35705950 Variant on Interstitial Lung Disease Risk in Patients With Rheumatoid Arthritis
2026Rheumatology (Oxford, England)PubMed
Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas
2025Joint bone spinePubMed
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort
2024Clinical and experimental rheumatologyPubMed
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2024Rheumatology (Oxford, England)PubMed
A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA)
2022Frontiers in medicinePubMed
Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study
2021Rheumatology and therapyPubMed
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)
2020Clinical and experimental rheumatologyPubMed
Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
2024Clinical and experimental rheumatologyPubMed
Two-year treatment persistence with subcutaneous abatacept in rheumatoid arthritis: results from the French cohort of the ASCORE study
2024Rheumatology (Oxford, England)PubMed
Can efficacy and safety data from clinical trials of rituximab in RA be extrapolated? Insights from 1984 patients from the AIR-PR Registry
2024Arthritis & rheumatology (Hoboken, N.J.)PubMed
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
2023International immunopharmacologyPubMed
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases
2021Rheumatology and therapyPubMed
Real-World 1-Year Retention Rate of Subcutaneous Tocilizumab Treatment in Patients with Moderate to Severe Active Rheumatoid Arthritis: TANDEM Study
2020Journal of clinical medicinePubMed
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
2026Rheumatology (Oxford, England)PubMed
Time and patient journey to axial spondyloarthritis diagnosis: a retrospective study in French primary care
2025Rheumatology advances in practicePubMed
Bone marrow oedema of the sacroiliac joint without spondyloarthritis: a retrospective study of 34 cases of osteitis condensans ilii
2024Clinical and experimental rheumatologyPubMed
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2022Joint bone spinePubMed
Factors associated with drug-free remission at 5-year in early onset axial spondyloarthritis patients: Data from the DESIR cohort
2021Rheumatology (Oxford, England)PubMed
VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy
2020Clinical and experimental rheumatologyPubMed
Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
2026Rheumatology (Oxford, England)PubMed
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025
2026The British journal of dermatologyPubMed
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025
2025Rheumatology (Oxford, England)PubMed
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024
2024The British journal of dermatologyPubMed
British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2024
2023Rheumatology (Oxford, England)PubMed
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial
2022Arthritis research & therapyPubMed
Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination
2020Journal of clinical medicinePubMed
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis
2026Autoimmunity reviewsPubMed
Altered reproductive hormone profiles in systemic lupus erythematosus - A systematic review and meta-analysis
2023Acta endocrinologica (Bucharest, Romania : 2005)PubMed
Estradiol in Systemic Lupus Erythematosus
2020LupusPubMed
Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review
2022Rheumatology (Oxford, England)PubMed
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL study
2021Rheumatology and therapyPubMed
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)
2025The Lancet. RheumatologyPubMed
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2022Arthritis research & therapyPubMed
Validation in the ESPOIR cohort of vitamin K-dependent protein S (PROS) as a potential biomarker capable of predicting response to the methotrexate/etanercept combination
2025Rheumatology and therapyPubMed
Prevalence and Significance of the Presence of Anti-transglutaminase and Anti-endomysium Antibodies in Patients with Early Inflammatory Joint Disease
2024The Journal of infectionPubMed
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry
2026Joint bone spinePubMed
Efficacy and Tolerance of a Combination of Targeted Therapies Indicated for Asthma and Chronic Inflammatory Rheumatism
2021iSciencePubMed
Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.